Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Sorption Technologies in Patients Receiving Program Hemodialysis With Inflammatory Syndrome

NCT07123909 is registered in ClinicalTrials.gov with Botkin Hospital as lead sponsor.

NCT NCT07123909
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07123909 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Sorption Technologies in Patients Receiving Program Hemodialysis With Inflammatory Syndrome
Lead sponsor
Botkin Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
June 1, 2025
Completion date
June 30, 2026
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anemia associated with end stage renal disease, ckd (chronic kidney disease) stage 5d, dialysis related complication, hemodialysis, inflammation biomarkers, inflammation chronic, uremia; chronic, uremic; toxemia